A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLC
A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLC
Active, not recruiting · NCT05844150 · Registry updated 2025-03-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLC | SCLC | Active, not recruiting | Phase 2 | 2025-03-12 | NCT05844150 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Biotheus Inc. | 10 |
17 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Anhui Provincial Hospital | Hefei | China | 34 |
| Beijing Cancer Hospital | Beijing | China | 85 |
| Central Hospital Affiliated to Shandong First Medical University | Jinan | China | 4 |
| Harbin Medical University Cancer Hospital | Harbin | China | 35 |
| Hebei Petro China Central Hospital | Langfang | China | 1 |
| Jilin Cancer Hospital | Changchun | China | 15 |
| Linyi Cancer Hospital | Linyi | China | 19 |
| Shandong Cancer Hospital | Shandong | China | 3 |
| Shanghai Pulmonary Hospital | Shanghai | China | 33 |
| Taizhou Hospital of Zhejiang Province | Taizhou | China | 11 |
| The Affiliated Hospital of Qingdao University | Qingdao | China | 22 |
| The First Affiliated Hospital of Chongqing Medical University | Chongqing | China | 34 |
| The First Affiliated Hospital of Guangzhou Medical University | Guangzhou | China | 20 |
| The First Affiliated Hospital of Nanchang University | Nanchang | China | 55 |
| The First Affiliated Hospital of Zhengzhou University | Zhengzhou | China | 61 |
| Tianjin Medical University General Hospital | Tianjin | China | 28 |
| Zhejiang Cancer Hospital | Hangzhou | China | 40 |